Adagene Announces Investigator Initiated Phase II Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal Cancer

Adagene, Inc. announced an investigator initiated Phase II neoadjuvant trial of ADG126 for patients with stage II or stage III colorectal cancer.